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Abstract 20 
Background: Açai (Euterpe oleracea) is a polyphenol rich, Amazonian fruit which has been 21 
suggested to have potential health benefits. There is however little direct evidence 22 
demonstrating improvements in health markers arising from açai consumption in humans. 23 
Objective: The objective of the present study was to investigate the effect of açai 24 
consumption on acute changes in vascular function, and on other cardiovascular and 25 
metabolic disease risk markers including postprandial plasma insulin, glucose and oxidative 26 
stress. 27 
Design:  Twenty-three healthy male volunteers, aged 30-65 y and with a body mass index 25-28 
30 kg/m
2
, completed a randomized, control controlled, high fat challenge, double-blind 29 
crossover acute dietary intervention trial. The volunteers were randomized to consume either 30 
an açai based smoothie (AS) or a macronutrient matched control smoothie (PS) alongside a 31 
high fat breakfast meal challenge. The primary endpoint was the assessment of endothelial 32 
function in the brachial artery using flow-mediated dilatation (FMD).  33 
Results: We observed that the acute consumption of an acai based smoothie containing 694 34 
mg of total phenolics improved vascular function, as measured by FMD, with post prandial 35 
increases from baseline  of 1.4% at 2 hours,  and 0.8% at 6 hours. There was also a 36 
significantly lower incremental area under the curve (IAUC) for total peroxide oxidative 37 
status after açai consumption relative to control.  No significant changes were observed in 38 
blood pressure, heart rate or the post-prandial glucose response. However, the first post-39 
prandial insulin peak (after breakfast) and the IAUC for insulin were elevated for açai relative 40 
to control.   41 
 3  
Conclusions: In this acute study in overweight men, açai consumption is associated with 42 
improvements in vascular function which may lower risk of a cardiovascular event.   Future 43 
intervention studies, perhaps with a chronic design, in wider populations, and with other 44 
biomarkers of disease risk are needed to fully elucidate açai benefits to health. 45 
Key words   Vascular Function, Açai (Euterpe oleracea), Flavonoids, Acute, FMD.  46 
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Introduction  61 
Dietary practices which reduce the burden of cardiovascular diseases (CVD) are a desirable 62 
goal of public health programs.  Prospective cohort studies strongly suggest that a diet high in 63 
fruit and vegetables may protect against CVD (1, 2). There is however a need to identify 64 
individual plant foods with strong protective effects and also to better understand the 65 
mechanisms involved in food mediated disease prevention (3). Polyphenols are widely 66 
studied non-nutritive bioactive compounds found in plant foods; these compounds have a 67 
well characterized free radical scavenging ability in vitro which may decrease oxidative stress 68 
in vivo (4). Polyphenols may also improve endothelial function, lower blood pressure (5, 6), 69 
improve insulin sensitivity (7), decrease low-density lipoprotein level (LDL) (8), and 70 
modulate inflammatory response (9). Dietary intervention with polyphenol rich berries 71 
induce improvements in risk factors associated with metabolic syndrome, diabetes and 72 
cardiovascular disease (10, 11).   73 
The flow mediated dilation (FMD) method is a measure of arterial endothelial dysfunction 74 
and a well-established early biomarker of cardiovascular disease risk (12). Dietary 75 
intervention with blueberry has been shown to reverse this endothelial dysfunction, at least in 76 
an acute setting, where changes in the concentration of phenolic metabolites in plasma were 77 
associated with observed post-prandial improvements in FMD (13). This suggests that 78 
polyphenols present in blueberry may mediate a benefical effect on FMD. Several other 79 
dietary intervention studies with polyphenol rich foods, including for example cocoa (14),  80 
green tea (15) and grapes (16) report similar improvements in FMD when test foods are 81 
consumed in an acute setting.  82 
The açai fruit (Euterpe oleracea Mart., Arecaceae) is notable for its 83 
very high concentration of flavonoids; this suggests potential health benefits from its 84 
 5  
consumption may exist. The food media have picked up on this despite a paucity of 85 
supporting human intervention study data. Açai has subsequently found its way into the 86 
global health food market (17, 18). In the UK consumption of açai remains very low; it is 87 
available as a powdered supplement or as a minor constituent of foodstuffs such as in mixed 88 
berry drinks or yoghurts, often these are marketed with loose claims for health. Some 89 
characterization of potential benefits from consuming açai is therefore necessary to better 90 
inform the consumer and to establish appropriate dietary recommendations for the prevention 91 
of disease (19) .  92 
To our knowledge, the effects of açai on arterial endothelial dysfunction have not been 93 
assessed. Here, we describe results from a double-blind control-controlled intervention trial 94 
with açai consumed as a smoothie blended with banana, as it is typically prepared in Brazil, 95 
and with FMD as the primary endpoint. We hypothesized that consuming açai, alongside a 96 
high fat breakfast intervention, would ameliorate the detrimental vascular response to that 97 
high fat intervention and induce improvements in other cardiovascular and metabolic disease 98 
risk markers in an acute setting.  99 
Subjects and Methods.  100 
Materials 101 
Frozen açai pulp was kindly donated by the Sublime Foods Company Ltd (UK). Fresh 102 
banana was purchased locally. Flavonoid and phenolic acid standards were obtained from 103 
Sigma-Aldrich Co Ltd, UK or Extrasynthese, France. Water, methanol, and acetonitrile 104 
(HPLC grade) were purchased from Fisher Scientific. Glucose concentrations were quantified 105 
using an iLAB 600 biochemical analyzer (Instrumentation Laboratory) with enzymatic 106 
colorimetric and standard kits with  appropriate sero-normal, low and high quality control 107 
standards supplied by Instrumentation Laboratories and Alpha Laboratories (IL Test TM 108 
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Glucose). Serum insulin was determined with an enzyme-immunoassay using reagents 109 
supplied by Dako Cytomation and a GENios plate reader (Tecan Group). Blood tubes for 110 
serum and plasma were supplied by Geriner BioOne Ltd (UK). All other chemicals and 111 
reagents were obtained from Sigma-Aldrich Co Ltd or Fisher Scientific.  112 
Intervention study subjects 113 
Twenty-three male volunteers were recruited from the University of Reading and surrounding 114 
area through the Hugh Sinclair Unit of Human Nutrition volunteer database, and through 115 
advertisements within the local community between September 2014 and January 2015. 116 
Volunteers were required to be of good general health but with a BMI of 25-30 kg m
2
 which 117 
is associated with a slight increase in risk of developing metabolic disease. The inclusion 118 
criteria were as follows: male, aged 30-65 years, non-smokers, total cholesterol <8.0 119 
mmol/ml. Volunteers were excluded if they suffered from diabetes, anemia, cardiovascular, 120 
renal, gastrointestinal, hepatic disease or were being medicated for hyperlipidemia, 121 
hypertension, inflammation or depression, if they were on a weight reduction program or 122 
were taking any nutritional supplements. Of the first 37 men screened 24 were recruited and 123 
randomized onto the crossover study arms, 23 participants completed the study with one drop 124 
out due to a change in his personal circumstances (Figure 1).  125 
Study design and treatments. 126 
The study was registered as a clinical trial (Clinical trials.gov ID: NCT02292329) and was 127 
conducted according to the Declaration of Helsinki and 128 
followed Good  Clinical Practice (GCP). It was given a favorable ethical opinion for conduct 129 
by the University of Reading Research Ethics Committee (Ethics reference number 13/51). 130 
The study was an acute randomized, controlled, double blind crossover study with an açai 131 
smoothie (study treatment). The volunteers were randomized using a minimization program 132 
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(www.users.york.ac.uk) by the researcher to generate the randomization sequence (with 133 
discrimination for age and BMI) for the treatment arms. Açai is very rarely consumed in this 134 
format in the UK and it was unfamiliar to the participants enabling us to effectively blind 135 
them to the treatment arm.  136 
Frozen açai pulp (150 g) was prepared in a smoothie with 50 g of banana and no other 137 
additives. Analysis of the nutritional profile of both smoothies can be seen in Table 1. The 138 
control smoothie was prepared from 50 g of banana and matched for fat by 1.5 g palmitic 139 
acid and 8.5g sunflower oil (30% oleic acid, 60% linoleic acid and 10% palmitic acid, both 140 
purchased from Sigma-Aldrich UK), carbohydrate (maltodextrin, Myprotein, UK) and fiber 141 
(cellulose, Azelis, UK) and then blended with artificial food colors (Sensientflavors,UK) to 142 
create a dark color approximating that of the açai smoothie. 150 g of açai contains 8.4 g fat 143 
(61.6% oleic acid, 12.6% linoleic acid and 25.7 % palmitic acid). The smoothies were 144 
prepared fresh in the early morning on the day of the intervention. 145 
Participants were given dietary advice directing them away from consuming polyphenol-rich 146 
foods for at least 24-hours prior to the study visits and each volunteer was asked to consume 147 
a standard low flavonoid evening meal containing <15g fat and <7g of saturated fat and to 148 
fast overnight (12 hours thereafter) prior to the intervention. A 24 hour dietary recall was also 149 
taken at each visit (Supplement table 1). The study visit began at 8am in the morning. 150 
Subjects were rested in the unit for 30 minutes prior to measurements of baseline blood 151 
pressure and FMD.  Blood (18 ml) was then collected via a cannula inserted into the 152 
antecubital vein of the forearm (Study procedure is shown in Supplement figure 1). 153 
Volunteers were then provided with a high fat challenge breakfast (50g fat) (Supplement 154 
table 2) and asked to consume the smoothie with it, and within a ten minute total time frame. 155 
An independent researcher, unaware of the study arm, collected blood samples at regular 156 
intervals for 7 hours (1, 2, 3, 4, 5, 6, 7 hours) and performed vascular measurements at 2 157 
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hours, 4 hours and 6 hours. A second lunch-time standard moderate fat (14.2g fat) meal was 158 
provided after collection of the 4th hour blood samples (Supplemental figure 1). Urine 159 
samples were collected at baseline, 0-7 and 7-24 hours. Subjects were given a standard low 160 
polyphenol evening meal at the end of the visit day to ensure phenolics recovered in the 24 161 
hour urines were from açai.  162 
Assessment of the polyphenol content of test foods.  163 
 Açai smoothies were prepared as described above. Samples were taken and freeze-164 
dried. Flavonoids and phenolic acids were extracted using acidified methanol with 0.1% 165 
formic acid for the anthocyanin compounds and methanol: water (80:20, v/v) for other 166 
phenols. The polyphenols were characterized using a method previously validated by our 167 
group (20). HPLC was performed using an Agilent 1100 series liquid chromatograph with a 168 
quaternary pump and a photodiode array detector (Hewlett–Packard Agilent, Bracknell, UK). 169 
A Nova Pak C18 4-µm column (4.6 × 250 mm) (Waters, Elstree, UK) was used to separate 170 
the phenolic constituents at a solvent flow rate of 0.4 mL/min and the column was allowed to 171 
equilibrate for 15 min between each injection. At least 50 µL of each sample or standard 172 
solution was injected for each analysis. The mobile phase A was 95% HPLC water, 5% 173 
methanol and 0.1% HCl; mobile phase B was 50% HPLC water, 50% acetonitrile and 0.1% 174 
HCl. The identification of phenolic compounds from açai was based on the mass spectra 175 
fragmentation patterns and retention times in the UV spectra compared with standards 176 
selected based on previous literature (17) . The detection wavelengths were 254, 280, 320 and 177 
520 nm. A standard curve was constructed to quantify the amount of each compound 178 
identified in açai smoothie (20). 179 
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Nitrite and nitrate in test foods.  180 
Nitrite and Nitrate were assessed in aqueous extracts of test foods using the ENO-30, HPLC-181 
based approach. Briefly, smoothies were prepared and mixed with distilled low nitrite/nitrate 182 
water (50:50). Samples were centrifuged at 3000g for 10 min and the supernatant passed 183 
through a 0.45µM syringe filter. 200 µl was collected and 10µl was immediately injected into 184 
the ENO-30 system. Calibration curves for nitrite and nitrate were prepared using NaNO2 185 
and NaNO3 standards in pure water. Carrier solution was prepared by using pure water (900 186 
ml) with methanol (100 ml) and carrier powder (obtained from Eicom, Ireland). Mobile phase 187 
A was prepared with pure water (450 mL), 100 mL of methanol, 12.5 mL of concentrated 188 
HCL (35-57%) and reactor A powder (obtained from Eicom, Ireland). Mobile phase B was 189 
prepared from pure water (450 mL) and 100 mL of methanol and Reactor Powder B 190 
(obtained from Eicom, Ireland), Solution A and B were mixed as 1:1. Separation was 191 
achieved using a NO-PAK Column size 4.6mm and 50mm and flow rate 100µl/min. Pump 192 
pressures were A 300 µl/min and B 100 µl/min. 193 
Vascular function and measurements 194 
FMD.  195 
Flow Mediated Dilation (FMD) of the brachial artery was the primary endpoint measure of 196 
the study and was measured according to standard guidelines (21) by using an ALT 197 
Ultrasound HDI-15000 system (ATL Ultrasound, UK) in combination with a semi-automated 198 
computerized analysis system (Brachial Analyzer; Medical Imaging Applications-IIc, IL, 199 
US). Briefly, after a 30 minute rest in the supine position in a quiet, temperature-controlled 200 
room (22-24 °C) a baseline vascular measurement was taken. Vascular measurements were 201 
taken at 2, 4 and 6 h after the meal. The brachial artery was imaged longitudinally at 2-10 cm 202 
proximal to the antecubital fossa. After baseline images were recorded over 60 seconds, a 203 
blood pressure cuff placed around the forearm was inflated to 220 mm Hg. Then after 5 min 204 
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of occlusion, the blood pressure was rapidly released to allow reactive hyperemia, with image 205 
collection that continued for 5 min after release. A single researcher who was blinded to the 206 
intervention analyzed all image files. The peak diameter was defined as the largest diameter 207 
obtained after the cuff was released. The FMD percentage was calculated as the relative 208 
diameter change from the baseline comparison with the peak diastolic diameter.  209 
Blood pressure measurements. 210 
Systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were 211 
measured in all subjects at baseline, 2h, 4h and 6h after the meal. Before measurement 212 
subjects were rested for 30 minutes and the mean of triplicate measurements was recorded 213 
with an OMRON-M6 automatic digital (HEM-7211-E8) Comfort Upper-Arm Blood Pressure 214 
Monitor.  215 
Biochemical analysis.   216 
Plasma blood samples were collected in EDTA vacutainers (Greiner BioOne Ltd) and kept on 217 
ice until centrifugation at 1600 x g for 15 minutes at 4º C. Vacutainer rapid serum separator 218 
tubes were used to collect blood and left at room temperature (RT) for 30 minutes to allow 219 
for clot formation, then centrifuged at 1600 x g for 15 minutes at RT to 220 
isolate serum. Urine samples were collected at different time points (0-7 and 7-24 hours) the 221 
total volume of urine produced each time point was recorded and aliquots were prepared for 222 
storage after centrifugation at 1600g for 10 minutes at 4ºC. Blood and urine samples were 223 
stored at -80ºC until further analysis. Serum lipids were measured at baseline via the iLAB 224 
600 and Low-density lipoprotein (LDL) was calculated from Friedewald equation. Total 225 
serum glucose and insulin were analyzed at all-time points (0, 1, 2, 3, 4, 5, 6, and 7h) using 226 
an ILAB600 auto-Analyzer (Warrington, UK). Serum insulin concentrations at each time 227 
point were analyzed using an enzyme linked immunosorbent assay (ELISA).  228 
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Total oxidant capacity (TOC) 229 
Total oxidant capacity in plasma was assessed as a measure of total peroxide levels according 230 
to the method of Tatzber et al. (22). Briefly, 10 µL of standards (0, 0.125, 0.25, 0.5, 1mmol/L 231 
of hydrogen peroxide (30%)) or plasma samples were added to the wells of a 96-well plate, 232 
followed by the addition of 200 µL of reaction mixture. The stock reaction mixture (prepared 233 
fresh) contained 20ml reaction buffer (phosphate-citrate 0.05M, pH 5.0), 20 ml of substrate 234 
solution (3,3',5,5'-Tetramethylbenzidine (TMB) solution at 1mg/ml in DMSO), and 20µl of 235 
peroxidase solution (10mg/ml in phosphate buffer 0.1M, pH 6.0).  The 96-well plate was 236 
incubated for 20 mins on ice and the reaction was then stopped by the addition 2M sulfuric 237 
acid. Absorbance was measured immediately at a wavelength of 450nm on a GENios plate 238 
reader at room temperature with Magellan
TM
 software.  239 
Statistical analysis and power calculations  240 
Power calculations were based on the primary endpoint, change in FMD, from baseline at 2 241 
hours, with a required sample size estimated based on the variance of repeated measurements 242 
in the control group and on control data. Based on previous acute studies of the effects 243 
flavonoid rich foods on FMD and aiming for statistically significant improvement in FMD of 244 
between 1.5 to 2%, with a baseline vasodilatation of 10%, 23 subjects were required to 245 
achieve a study power of 80 % with alpha at 0.05.   246 
Results are expressed as mean, SEM. Data were checked for normal distribution. Two-factor 247 
repeated measures ANOVA was used to analyze the data for FMD, blood pressure, and 7 248 
hours in postprandial glucose, insulin and total plasma oxidant capacity following the two 249 
treatments.  250 
The incremental area under the curve (IAUC) over 7 hours was calculated for insulin, glucose 251 
and TOC using the trapezoidal method excluding the area below fasting level (23). The 252 
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timings of the maximum concentration (MaxC) of serum glucose and insulin after each meal 253 
were calculated (Tmax
1-4h 
and Tmax
4-7h
) and used in the analysis by Paired samples t-test. 254 
Significance was defined as P<0.05 with p-values represented in the figures as ***P<0.001, 255 
**P<0.01, *P<0.05. All statistics were performed using SPSS software (Version 18).  256 
Results 257 
Baseline characteristics of the study participants.  258 
The baseline characteristics of the study population are summarized in Table 2. The enrolled 259 
subjects were men at slightly elevated risk of metabolic syndrome with a BMI in the 260 
overweight category and a mean age of 46 (SEM 1.9 years). At screening the subjects had a 261 
mean waist circumference of 97.6 cm (SEM 1.6 cm) and serum lipids within the normal 262 
range (Table 2). The subjects were normoglycemic, test results for hemoglobin and for liver 263 
function showed no evidence of ill health. Blood pressure (SBP and DBP) and heart rate were 264 
also within the acceptable healthy range. No side effects were reported by the study 265 
participants. 266 
Polyphenol content of smoothies 267 
The polyphenol and phenolic acid content of the açai smoothie was 694 mg (Table 1). Its 268 
total anthocyanin content was 493 mg (principally cyanidin-3-O-glucoside, cyanidin-3-O-269 
rutinoside, pelargonidin-3-O-glucoside and peonidin-3-O-rutinoside), the quercetin content 270 
was 9.6 mg and gallic acid content 173.6 mg.  Small amounts of some phenolic acids such as 271 
caffeic acid, ferulic acid, vanillic acid, 3, 4-dihydroxybenzoic acid, 4-hydroxybenzoic acid 272 
and 2, 5-dihydroxybenzoic acid were also identified and quantified in the açai smoothie 273 
(Table 1). The polyphenol content of the control smoothie was below the level of detection  274 
(< 10mg). 275 
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Vascular function.  276 
Flow  mediated dilation (FMD) changed from baseline over the course of the study day (two-277 
way ANOVA, time effect; P=0.028), peaking 2 hours after the test meal was consumed and 278 
again at 6 hours (Figure 2). Moreover, there was a highly significant treatment effect on FMD 279 
for the acai smoothie relative to control (two-way ANOVA, treatment effect; P<0.001).  280 
However the time by treatment interaction was not significant (P=0.2).  281 
The primary endpoint for this study was the change from baseline in FMD at 2 hours, the 282 
magnitude of increase in FMD from baseline after consumption of the açai smoothie was 283 
1.4% (SEM 0.6%) (p=0.034, T-test), compared to only a 0.4% (SEM 0.6 %) (p=0.52) 284 
increase after consumption of the control. After 4 hours, the FMD measurements for the acai 285 
group had dropped to a 0.2% (SEM 0.5%) increase above baseline, whereas the control fell to 286 
-0.5% (SEM 0.7%) below that of baseline levels.  A second peak in FMD was observed at 6 h 287 
hours post intervention with the acai smoothie to 0.8% (SEM 0.7%.), whilst the control 288 
remained slightly below baseline (-0.3% (SEM 0.5%). (Figure 2).  289 
No significant differences in systolic blood pressure, diastolic blood pressure or heart rate 290 
were observed between the treatment groups over the course of the study day (Table 3).  291 
Postprandial glucose and insulin response.  292 
As expected, consumption of the breakfast resulted in a rapid rise in serum glucose 293 
concentration peaking on average at 1 hour (5.90 ±0.23 mmol/L with the açai smoothie and 294 
5.28 ± 0.27 mmol/L with the control smoothie) and then returning to baseline between 2 to 4 295 
hours (Figure 3 A).  After consumption of the lunch, serum glucose concentrations again 296 
increased, reaching a higher maximum (7.49 ± 0.24 mmol/L with the açai smoothie and 6.75 297 
± 0.29 mmol/L with the control smoothie) than after breakfast. No significant differences in 298 
the incremental area under the curve for serum glucose were observed between the two 299 
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treatments and no time by treatment interaction was observed (P=0.38) (Figure 3 B). The 300 
postprandial serum insulin response to the sequential mixed meals is shown in Table 4. 301 
Significant treatment (P=0.02) and time (P<0.001) effects were observed. The açai smoothie 302 
induced a significantly higher maximum insulin concentration (maxC 
1-4h
) (P=0.009) than the 303 
control and significant differences were found in  the IAUC (P=0.003). However, no time (h) 304 
x treatment interaction was observed (P=0.15). 305 
Total oxidant capacity.  306 
The post-prandial total plasma oxidant capacity over seven hours following consumption of 307 
the açai smoothie or control is shown in (Figure 3 C).  The IAUC over the 7 hour study 308 
period shows significantly lower total plasma oxidants for the açai smoothie relative to 309 
control (P=0.02) (Table 4). No significant differences were observed at any individual 310 
sampling time-point over this period and the time (h) x treatment interaction  was P=0.68.   311 
Discussion  312 
To our knowledge, this is the first human study demonstrating the effects of consuming açai, 313 
with a high fat breakfast, on vascular function and other metabolic disease risk markers, in an 314 
acute setting. We hypothesized that consuming açai would ameliorate the detrimental 315 
vascular response to a high fat meal and induce improvements in other cardiovascular and 316 
metabolic disease risk markers in an acute setting. Our study demonstrates that açai induces 317 
clinically meaningful improvement in vascular function (FMD) in overweight individuals (a 318 
1.4% increase at 2 hours). At a  population level, a 1% increase in FMD is associated with a 319 
13% reduction in risk of a cardiovascular event (24).   320 
We speculate that the polyphenols present in the açai were responsible for these changes in 321 
vascular function. No time by treatment effects were observed in FMD following 322 
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consumption of the acai smoothie versus the control smoothie over the six hour intervention 323 
window. A comparison of the composition of the açai versus the control food revealed that 324 
the control smoothie was matched to within 1% for energy and for fiber, to within 10% for 325 
carbohydrate and to within 20% for total fat, the control had a slightly higher nitrate content 326 
but a lower nitrite content; the total content of nitrite/nitrate in the control was double that of 327 
the açai smoothie. In contrast, the açai smoothie contained 694 mg of flavonoids and phenolic 328 
acids versus less than 10 mg in the control smoothie. Our approach, using a whole food as 329 
opposed to purified phenolic isolates, does not allow us to fully assess whether it is the 330 
polyphenols present in the food mediating the observed response, and we cannot completely 331 
exclude the possibility that other known or unknown compounds might be responsible for the 332 
biological outcomes. Both acute and chronic dietary interventions with other plant 333 
polyphenol rich foods such as blueberries (13), pomegranate juice (25), dark chocolate (6) 334 
and cocoa  (14, 26, 27) induce similar changes in vascular function, and purified flavonoids 335 
have also been shown to induce this effect in hypercholesteremic volunteers (28). We 336 
observed peaks in FMD at 2 and 6 hours post consumption of the açai smoothie, Rodriguez et 337 
al. identified similar peaks in post-prandial FMD in healthy men fed blueberry at 2, and 6 338 
hours, and this correlated with peaks in plasma concentrations of phenolic acid metabolites 339 
and a reduction of neutrophil NADPH oxidase activity in that study (13). This time course 340 
may reflect the emergence of phenolic metabolites in plasma following small intestinal 341 
absorption and later, at 6 hours, the liberation of phenolic compounds during colonic 342 
fermentation (29-31) 343 
The mechanism by which phenolics improve endothelial function is unclear, it is possible that 344 
it is related to their well-established antioxidant activity (32, 33). One hypothesis is that 345 
phenolics may reduce NADPH oxidase activity and that this may be linked to an increased 346 
level of nitric oxide via inhibition of superoxide production (34, 35).  347 
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We observed no changes in blood pressure at any time point after açai smoothie intake. This 348 
is similar to another açai study that reported no effect on blood pressure after having 100g of 349 
açai pulp twice daily for one month (36) and in line with findings from previous acute 350 
interventions with polyphenol rich foods (13, 37). However, chronic, or longer term, 351 
interventions with polyphenol rich foods, fed to high risk groups, are often shown to be 352 
effective at lowering blood pressure (6, 25, 38-41).  353 
No differences were observed in post-prandial glucose responses between the açai smoothie 354 
and the carbohydrate and energy matched control, but a significantly higher insulin response 355 
was observed for the açai compared to control. Zunino and others have argued that phenolics 356 
can improve  glucose control although the mechanism has not been elucidated (42), findings 357 
from studies of other polyphenol rich foods are not consistent when it comes to their effects 358 
on plasma glucose and insulin (7, 8, 30, 43-50).  Further work is clearly needed to understand 359 
this elevated insulin response and to determine whether or not it may be clinically relevant to 360 
glucose control.  361 
We also observed a reduction in total peroxide levels in plasma following consumption of the 362 
açai which we included as a measure of acute changes in plasma oxidant capacity. Again we 363 
hypothesize that this is a function of phenolics emerging in plasma; previously the 364 
consumption of grape polyphenols induced similar effects in pre-and postmenopausal women 365 
(50).  In experimental models oxidative stress is strongly linked to endothelial function and to 366 
cardiovascular disease (51, 52), Measures of plasma oxidant capacity are however widely 367 
critiqued, and our observation therefore warrants follow up using different measures such as 368 
the presence of oxidized LDL following a longer term intervention.   369 
A limitation of the present study is that we did not determine and correlate directly 370 
polyphenols and their metabolites in plasma or urine in tandem with our FMD measures and 371 
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nitric oxide as assessed by Rodriguez-Mateos in an intervention with blueberry (13). Our 372 
study was a short term acute intervention in overweight middle aged men, selected as a high 373 
risk group for cardiovascular disease. We cannot infer the long term effects of açai 374 
consumption on vascular function, or rule out physiological adaptations to the presence of 375 
high quantities of açai polyphenols in the diet which might off-set the observed short-term 376 
benefits reported here. Future studies might consider chronic study designs, and data are still 377 
needed on the effects of açai consumption in other groups.   378 
This trial is the first well controlled acute intervention study in humans demonstrating actual 379 
benefits from consuming açai using a well validated biomarker of cardiovascular disease risk 380 
as an endpoint. The findings of this double-blind randomized crossover study are therefore 381 
timely and important and suggest that consuming açai as part of a balanced diet and a healthy 382 
lifestyle may improve cardiovascular health which strongly supports arguments for the health 383 
benefits of açai consumption. 384 
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Table 1: Composition and Nutritional Profile of a 200g serving of the Intervention Foods
1
. 
 
 
 
 1 
The energy, protein, sugar, fat, fiber, vitamin C and sugar content were 
analyzed under contract by Campden BRI laboratories (UK). Identification 
and quantification of phenolic compounds in açai smoothie was assessed by 
HPLC. 
 
 
 
 
Compounds Açai smoothie  Control smoothie (control) 
Energy (Kcal)  154.5 155.3 
Protein (g)  2.4 0.6 
Fat (g) 
Carbohydrate (g) 
8.5 
17.2 
10 
16 
Fiber (g) 7.2 7.2 
Fructose (g) 2.68 3.8 
Glucose (g) 2.92 4.12 
Total  sugar (g) 8.4 11.2 
Vitamin C (mg/L) 4.35 8.65 
Total  carotenoids (mg) 179.3 0 
Nitrite (µM/L)   0.07 0.04 
Nitrate (mM/L) 8.83 16.4 
Anthocyanins (mg) 493 0 
Chlorogenic  acid (mg) 9.3 0 
Caffeic acid(mg) 2.0 0 
Syringic acid (mg) 2.7 0 
Ferulic acid (mg) 0.6 0 
Vanillic acid (mg) 0.2 0 
Gallic acid (mg) 173.6 0 
3,4-Dihydroxybenzoic acid (mg) 1.2 0 
4-Hydroxybenzoic acid (mg) 0.8 0 
2,5-Dihydroxybenzoic acid (mg) 0.4 0 
Trans-cinnamic acid (mg) 0.4 0 
Quercetin (mg) 9.6 0 
Total  phenols  (mg) 694 <10 
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Table 2: Baseline clinical characterization of study population
1
  
Characteristics                           Mean   SEMs  
   n 23 - 
   Age (years)  46 1.9 
   Body weight (kg) 88.8 2 
BMI (kg/m
2
) 27.6 0.4 
   Waist circumference, cm 97.6 
 
1.6 
 
Body Fat (%) 26.3  2    
Cholesterol (mmol/l) 5.1 0.2 
   Triglycerides (mmol/L)  1.3 0.1 
   HDL (mmol/L) 1.2 0.05 
   LDL (mmol/L) 3.2  0.1 
   Glucose, (mmol/L) 5.2  0.09 
   Creatinine (µmol/L) 95 1.8 
   Bilirubin (µmol/L) 11.7 0.7 
   Urea (µmol/L) 337  10 
   Haemoglobin (g/L) 148  1 
   SBP (mm Hg) 126 2 
   DBP (mm Hg) 75 2 
   Heart Rate (bpm) 63 2 
   1All values are means, SEMs (n = 23). Abbreviations: BMI, body mass index; DBP, 
diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
SBP, systolic blood pressure.  
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Table 3: Acute effects of açai polyphenols on blood pressure and heart rate (n=23)
1
. 
1 
All values are mean, SEM (n=23). No significant differences were shown between 
baseline and post-intervention (2, 4, or 6 h) or between the açai smoothie and control 
treatments, P>0.05 for SBP, DBP and heart rate (repeated-measured and 2-factor 
repeated-measures ANOVA). There were no significant time x treatment effects for 
SBP, DBP or for HR (SBP =P=0. 6), (DBP P=0.9) HR P=0.7). DBP, diastolic blood 
pressure; SBP, systolic blood pressure; HR, heart rate.  
 
 
 
 
 
 
 
 
 
 
Measures 
Timepoint 
Baseline SEM 2 h  SEM 4 h  SEM 6 h  SEM 
SBP (mm Hg)          
Açai smoothie 125.8 11.8 121.9
 
16 127 13.6 128.9 12.8 
Control 127.9 12.5 125.7 11.3 127 13.6 127.4 10.9 
DBP (mm Hg)         
Açai smoothie 73.7 8.9 72.1 9.8 74.1 9.3 74.3 10.4 
Control 73.7 10 72.2 8 74.5 9.8 75.1 8.2 
Heart rate 
(beats/min)  
        
Açai smoothie 59.1 8.8 61.2 9.9 57.2 8 61.9 10.2 
Control 58.3 8.3 57.6 8 56.4 8.2 58 7.3 
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Table 4: Postprandial measures of glucose and insulin responses and total oxidant capacity
1
.  
 
 
1 
Values represent mean ,  SEM. Two-way repeated measures ANOVA were  initially 
used to assess treatment, time and treatment by time interaction effects; when no 
differences were observed we performed paired samples t-tests to compare incremental 
area under the curve (IAUC) and observations at individual timepoints with the açai 
smoothie relative to control. 
Abbreviations; maxC, the maximum concentration; Tmax, the time to reach maxC; 
IAUC, incremental area under the curve.  
 
 2-3
 significantly different to control, P<0.01 
4
significantly different to control, P<0.05 
 
Measures 
 Smoothies   
Control  SEM Açai  SEM 
   Glucose response      
maxC
1-4h
 (mmol/L) 6.11 0.19 6.18 0.19 
Tmax
1-4hours 
 (hours) 1.61 0.15 1.30 0.13 
maxC
4-7h 
(mmol/L) 7.57 0.27 7.95 0.24 
Tmax
4-7hours
 (hours) 5.78 0.14 5.87 0.11 
IAUC (mmol/L ×hour) 2.35 1.13 3.42 1.10 
Insulin response      
maxC
1-4h
 (pmol/L) 246.4 24.1 319
2 
26.44 
Tmax
1-4hours 
 (hours) 1.57 0.12 1.22 0.09 
maxC
4-7h 
(pmol/L) 302 29.8 323 26.4 
Tmax
4-7hours
 (hours) 5.91 0.15 5.83 0.12 
IAUC (pmol/L ×hour) 733 86.3 907.7
3 
76.5 
Oxidative capacity     
       maxC
1-4h
 (µmol/L) 310.3 20.7 310.8 19.5 
Tmax
1-4hours 
 (hours) 1.3 0.1 1.3 0.2 
maxC
4-7h 
(µmol/L) 293.5 20.8 294.5 17.0 
Tmax
4-7hours
 (hours) 5.6 0.2 5.4 0.2 
IAUC (µmol/L ×hour) -30.5 127.4 -165
4
 128.1 
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Figure legends 
Figure 1: Flow of the study participants through the intervention. 
Figure 2: FMD after consumption of an açai smoothie (AS) containing 694 mg of 
polyphenols or a macronutrient matched control smoothie (PS) (n = 23). Data were analyzed 
using a 2- factor repeated measures ANOVA with time and treatment as the two factors 
[significant effect of time (P=0.03), treatment (P=<0.001)]. At baseline the treatment arms 
are not significantly different (P=0.31). There was no significant interaction of time x 
treatment (P=0.2) reflecting the similar, but much attenuated, pattern of FMD measures 
through the day in the control relative to treatment.  
 
Figure 3: Mean, SEM for post-prandial serum glucose (A), insulin (B) and total plasma 
oxidant capacity (C) responses to a high-fat breakfast (50 g fat) and a standard lunch (14 g 
fat). The smoothies were consumed by volunteers with the breakfast meal only. The vertical 
line represents the timing of the lunch meal. Two-way repeated measures ANOVA was used 
to assess treatment, time and treatment by time interaction effect, and Paired samples t-test 
were used to compare incremental area under the curve (IAUC) between the açai smoothies 
relative to control.   
A. Glucose response: Treatment effect, P=0.14; Time effect, P<0.001; Time by 
Treatment interaction, P=0.38.  
B. Insulin response: Treatment effect, P=0.02; Time effect, P<0.001; Time by Treatment 
interaction, P=0.15. 
C. Total plasma oxidant capacity: Treatment effect, P=0.85; Time effect, P=0.36; Time 
by Treatment interaction, P=0.68. Incremental area under the curve (IAUC), P=0.02. 
